International vendor directory — need advice

VendorMark said:

It helps to ask what evidence would change your mind before you look at any.

Adding the part of the answer the thread has not reached. The pattern that distinguishes a bad batch from an exit is behaviour rather than product. A bad batch comes with communication, a reshipment offer and a batch number. An exit comes with slower replies, pressure toward less reversible payment methods, sudden discounting, and the same reassurance repeated without any new information. The product tells you less than the correspondence does.

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

One thing that is still open after VendorMark’s answer:

What a vetting checklist should actually contain, as opposed to a list of things that are easy to fake?

BiostatsBrad said:

If you are going to change something, change one thing and give it long enough to express itself.

I read this differently from BiostatsBrad, on substance rather than tone. Filing an objection on the n=1 problem. Personal experience is genuine evidence about one person and very weak evidence about anybody else, and this thread keeps promoting the first into the second.

Reporting back.

Coming back a few months on. It held. Nothing dramatic to report, which is the report.